Core Insights - The article discusses the breakthrough of the "Lingxi Continuous Dynamic Blood Pressure Watch," which addresses the challenges of continuous blood pressure monitoring, a critical health indicator closely related to cardiovascular health [3][10] Group 1: Technological Breakthroughs - The watch utilizes a unique combination of PPG (Photoplethysmography) and micro-pressure technology, allowing for accurate and comfortable blood pressure measurements without the discomfort of traditional methods [5] - It enables continuous monitoring of nighttime blood pressure, which has been overlooked in traditional methods, providing valuable data for predicting cardiovascular events [6] - The device is designed for a wide range of users, from diagnosed hypertension patients to healthy individuals, offering personalized health management solutions [8] Group 2: User Experience and Functionality - The watch features independent 4G communication, allowing for real-time data upload and emergency contact capabilities, enhancing user safety in critical situations [8] - It simplifies the calibration process through AI clustering, making it user-friendly and potentially reducing the need for frequent calibrations in the future [9] - The collaboration between Tsinghua University and Lingxi Bio represents a successful integration of academic research and market application, aiming to improve public health management [10]

本报讯(记者桂小笋)在全球可穿戴设备市场从"消费级"迈向"医疗级"的关键转折点，一款来自中国的创 新产品正引发行业瞩目。11月12日，《证券日报》记者获悉，灵析生物科技(深圳)有限公司(以下简 称"灵析生物")与清华大学微电子学研究所、心永科技联合研发联合打造的灵希连续动态血压手表，不 仅实现了无袖带、连续动态血压监测的技术突破，更成为All in One健康监测趋势下的一个标杆案例。 这标志着中国科研力量正在为全球高血压管理提供全新的"中国方案"。 据悉，通过内置4G模块，灵希连续动态血压手表实现了数据的实时传输与远程预警，曾成功预警用户 因重复服药导致的危险低血压事件，展现了其在主动健康管理中的潜力。这也契合了医疗可穿戴设备的 发展趋势：从单一的"监测硬件"向"传感器+AI+服务"的一体化健康平台演进。李毅彬介绍："未来设备 将更加无感、便携，并深度融合用药管理、生活方式指导等功能，最终成为一个比用户更了解其身体状 况的个人健康中枢。与灵析生物的合作，正是为了加速这一愿景的实现。" "市场已经证明，单一的功能迭代无法构筑长期壁垒。未来的核心竞争力在于医疗级精度与消费级体验 的融合，以及基于连续数据构建的健 ...